GlassScriptPhysician profile
Alison E Hiatt
NPI 1891045217
$2,152.54
in general payments reported to CMS, 2019-2025
38 companies · $827 in 2025
The $827 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $31.80 · 2023: $625 · 2024: $669 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,120.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $215.20 | 2023-2025 | |
| Pfizer INC. | $178.84 | 2022-2025 | |
| Janssen Biotech, INC. | $170.05 | 2023-2025 | Erleada, Darzalex, Tecvayli |
| Astrazeneca Pharmaceuticals LP | $147.22 | 2023-2025 | Imfinzi, Enhertu |
| Celgene Corporation | $129.03 | 2023 | Pomalyst, Reblozyl |
| Takeda Pharmaceuticals U.S.A., INC. | $117.79 | 2023-2025 | Ninlaro, Trintellix, Iclusig |
| Incyte Corporation | $107.05 | 2023-2025 | Monjuvi, Jakafi, Zynyz |
| E.R. Squibb & Sons, L.L.C. | $87.73 | 2023-2025 | Opdivo, Opdualag |
| Abbvie INC. | $86.74 | 2024-2025 | |
| Genentech USA, INC. | $80.74 | 2023-2025 | Polivy, Columvi, Lunsumio |
| Merck Sharp & Dohme LLC | $65.64 | 2024-2025 | Keytruda, Welireg, Lynparza |
| Aveo Pharmaceuticals, INC. | $53.58 | 2023-2025 | Fotivda |
| Lilly USA, LLC | $52.82 | 2024-2025 | Verzenio, Jaypirca |
| Array Biopharma INC | $46.57 | 2023-2025 | Xalkori, Braftovi, Lorbrena |
| Gilead Sciences, INC. | $46.12 | 2023-2024 | Trodelvy |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Hiatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.